A detailed history of Valley National Advisers Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Valley National Advisers Inc holds 484 shares of MRNA stock, worth $31,823. This represents 0.01% of its overall portfolio holdings.

Number of Shares
484
Previous 464 4.31%
Holding current value
$31,823
Previous $49,000 16.33%
% of portfolio
0.01%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$101.21 - $166.61 $2,024 - $3,332
20 Added 4.31%
484 $57,000
Q1 2024

Apr 19, 2024

SELL
$85.37 - $115.44 $4,097 - $5,541
-48 Reduced 9.38%
464 $49,000
Q4 2023

Jan 25, 2024

SELL
$69.51 - $104.43 $1,807 - $2,715
-26 Reduced 4.83%
512 $50,000
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $192 - $253
2 Added 0.37%
538 $56,000
Q2 2023

Jul 31, 2023

BUY
$118.5 - $160.53 $1,066 - $1,444
9 Added 1.71%
536 $66,000
Q1 2023

Apr 26, 2023

BUY
$135.66 - $197.02 $13,566 - $19,702
100 Added 23.42%
527 $73,000
Q4 2022

Jan 12, 2023

BUY
$118.38 - $210.04 $5,682 - $10,081
48 Added 12.66%
427 $79,000
Q3 2022

Nov 08, 2022

BUY
$118.07 - $194.18 $472 - $776
4 Added 1.07%
379 $51,000
Q2 2022

Jul 15, 2022

BUY
$117.13 - $176.59 $5,387 - $8,123
46 Added 13.98%
375 $65,000
Q1 2022

May 06, 2022

BUY
$126.46 - $235.05 $11,128 - $20,684
88 Added 36.51%
329 $57,000
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $8,355 - $13,634
37 Added 18.14%
241 $61,000
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $1,331 - $2,906
6 Added 3.03%
204 $79,000
Q2 2021

Aug 02, 2021

BUY
$129.91 - $234.98 $1,558 - $2,819
12 Added 6.45%
198 $47,000
Q1 2021

May 07, 2021

BUY
$109.18 - $185.98 $1,419 - $2,417
13 Added 7.51%
186 $24,000
Q4 2020

Feb 11, 2021

SELL
$65.74 - $169.86 $3,286 - $8,493
-50 Reduced 22.42%
173 $18,000
Q2 2020

Aug 10, 2020

SELL
$29.67 - $80.0 $5,162 - $13,920
-174 Reduced 43.83%
223 $14,000
Q1 2020

May 13, 2020

BUY
$17.78 - $31.58 $7,058 - $12,537
397 New
397 $12,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.